Impact of Augmented Reality During Robot-assisted Radical Prostatectomy
Recruiting
N/A
Interventional Study
Prostatic Neoplasm
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 70
- Sex
- Male
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 318 (estimated)
- Sponsor
- European Institute of Oncology · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Accurate preservation of neuro-vascular bundles is crucial in guaranteeing erectile function recovery after robot assisted radical prostatectomy (RARP). However, the nerve sparing approach is associated with higher rates of positive surgical margins (PSM) at final pathology. Augmented reality (AR) RARP was previously associated with a 10-15% reduction in the rates of PSMs in two retrospective seri…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Untreated, biopsy-proven adenocarcinoma of the prostate Age ≥18 years
European Association of Urology (EAU) low or intermediate risk prostate cancer:
* PSA≤20 ng/ml
* cT≤2b
* International Society for Urological Pathology \[ISUP\] grade group≤III Written informed consent provi…
Contacts